GlassScriptPhysician profile
Mark Lewis Mason
NPI 1770699340
$1,150.46
in general payments reported to CMS, 2019-2025
12 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $81.95 · 2021: $75.66 · 2022: $173 · 2023: $344 · 2024: $139 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.04 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $498.71 | 2019-2025 | Total30, Precision7, Precision 1 |
| Coopervision INC. | $194.59 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $113.12 | 2023-2024 | Infuse, Miebo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.80 | 2022 | |
| Abb Con-Cise Optical Group LLC | $52.65 | 2019-2024 | Contact Lens, Spectacle Lenses |
| Johnson & Johnson Vision Care, INC. | $42.35 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $39.45 | 2022 | |
| Carl Zeiss Meditec, INC. | $38.46 | 2019 | |
| Optos, INC. | $29.59 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.19 | 2019 | |
| Kala Pharmaceuticals, INC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.